EORTC’s presence at ESMO 2023
17 Oct 2023
New findings and upcoming EORTC trials in lung, head and neck, breast and rare cancers will be presented at ESMO 2023 in Madrid, highlighting EORTC’s commitment to innovative non-commercial cancer research. Seven abstracts have been accepted, with one of them being an oral presentation. Additionally, EORTC’s Scientific Director, Jan Bogaerts, will delve into the realm of pragmatic trials during a special session on Sunday, 22 October 2023. For a comprehensive overview of EORTC’s activities at ESMO, please refer to the table below.
EORTC presentations:
Presentation title | Presentation details |
---|---|
Setting International Standards in Analysing Patient-Reported Outcomes and Quality of Life Endpoints (SISAQOL-IMI): Two years update Madeline Pe, Belgium |
Friday, 20 October 2023 at 2:00 PM Room: Ávila Auditorium – NCC |
Pragmatic Trials Jan Bogaerts, Belgium |
Sunday, 22 October 2023 at 10:15 AM Room: León Auditorium – Hall 7 |
EORTC abstracts accepted at ESMO:
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024